Artificial Intelligence-Based Prediction of Cardiovascular Diseases from Chest Radiography

• Published in: Journal of imaging 2023-10, Vol.9 (11), p.236
• Main Authors: Farina, Juan M, Pereyra, Milagros, Mahmoud, Ahmed K, Scalia, Isabel G, Abbas, Mohammed Tiseer, Chao, Chieh-Ju, Barry, Timothy, Ayoub, Chadi, Banerjee, Imon, Arsanjani, Reza
• Format: Article
• Language: English
• Subjects: Accuracy; Algorithms; Aorta; Artificial intelligence; Automation; Availability; Cardiac function; Cardiovascular disease; Cardiovascular diseases; Chest; chest radiography; Computer-aided medical diagnosis; Coronary artery disease; deep learning; Diagnosis; Health aspects; Heart; Heart diseases; Heart failure; Hypertension; Medical research; Medicine, Experimental; Methods; Mortality; Pulmonary arteries; Pulmonary hypertension; Radiography; Risk factors
• ISSN: 2313-433X; 2313-433X
• DOI: 10.3390/jimaging9110236

Chest radiography (CXR) is the most frequently performed radiological test worldwide because of its wide availability, non-invasive nature, and low cost. The ability of CXR to diagnose cardiovascular diseases, give insight into cardiac function, and predict cardiovascular events is often underutilized, not clearly understood, and affected by inter- and intra-observer variability. Therefore, more sophisticated tests are generally needed to assess cardiovascular diseases. Considering the sustained increase in the incidence of cardiovascular diseases, it is critical to find accessible, fast, and reproducible tests to help diagnose these frequent conditions. The expanded focus on the application of artificial intelligence (AI) with respect to diagnostic cardiovascular imaging has also been applied to CXR, with several publications suggesting that AI models can be trained to detect cardiovascular conditions by identifying features in the CXR. Multiple models have been developed to predict mortality, cardiovascular morphology and function, coronary artery disease, valvular heart diseases, aortic diseases, arrhythmias, pulmonary hypertension, and heart failure. The available evidence demonstrates that the use of AI-based tools applied to CXR for the diagnosis of cardiovascular conditions and prognostication has the potential to transform clinical care. AI-analyzed CXRs could be utilized in the future as a complimentary, easy-to-apply technology to improve diagnosis and risk stratification for cardiovascular diseases. Such advances will likely help better target more advanced investigations, which may reduce the burden of testing in some cases, as well as better identify higher-risk patients who would benefit from earlier, dedicated, and comprehensive cardiovascular evaluation.